Crossmark

Exploring autism symptoms in an Australian cohort of patients with Prader-Willi and Angelman syndromes

Crossref DOI link: https://doi.org/10.1186/s11689-018-9242-0

Published Online: 2018-08-06

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Baker, Emma K. http://orcid.org/0000-0003-1165-0490
Godler, David E.

Bui, Minh

Hickerton, Chriselle

Rogers, Carolyn

Field, Mike

Amor, David J.

Bretherton, Lesley
Funding

Funding for this research was provided by:

National Health and Medical Research Council (104299; 1103389)

The Foundation for Prader-Willi Syndrome Research (USA) (43445; 501393)

Prader-Willi Syndrome Association (Australia)

Foundation for Angelman Syndrome Therapeutics

Dup15q Australia Ltd

Murdoch Children's Research Institute

Medical Research Future Fund (MRF1141334)

Financial Markets Foundation for Children (2017-361)

Genetics of Learning Disability (GOLD) Service
License Information

Text and Data Mining valid from 2018-08-06
More Information

Article History

Received: 26 November 2017

Accepted: 23 July 2018

First Online: 6 August 2018

Ethics approval and consent to participate

: All procedures were approved by The Royal Children’s Hospital Human Research Ethics Committee (HREC #33066). All parents/caregivers provided written consent, and those aged 18 years and above, who were deemed cognitively able, also provided written consent.

: Not applicable

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.